Staphylococcal nuclease and tudor domain containing 1 mRNA 3′ untranslated region (SND1 mRNA 3′UTR) (SND1 mRNA 3′UTR)

The Staphylococcal nuclease and tudor domain containing 1 (SND1) mRNA 3′ untranslated region (3′UTR) is a critical regulatory segment of the SND1 transcript that controls its stability and translation (UniProt Q7KZF4). SND1, also known as Tudor-SN or p100, is a multifunctional protein that plays a significant role in the RNA-induced silencing complex (RISC), mRNA splicing, and transcriptional regulation. The 3′UTR contains multiple binding sites for microRNAs, such as miR-184, miR-320a, and miR-361-5p, which normally function to suppress SND1 expression in healthy tissues (PubMed 25600155, 26109423). In various cancers, including hepatocellular carcinoma, glioma, and colorectal cancer, the downregulation of these microRNAs or alterations in the 3′UTR leads to SND1 overexpression, which drives oncogenic processes like cell proliferation, epithelial-mesenchymal transition (EMT), and metastasis (PubMed 24510034). As a result, the SND1 mRNA 3′UTR is an emerging therapeutic target for RNA-based interventions, such as miRNA mimics or antisense oligonucleotides, aimed at restoring normal SND1 levels. These strategies leverage the natural RNA interference machinery to induce mRNA degradation or block translation, thereby inhibiting tumor growth. However, the clinical application of such therapies faces hurdles including the need for efficient delivery systems and the potential for off-target effects on other transcripts.

Other names

SND1 3′UTRTudor-SN mRNA 3′UTRp100 mRNA 3′UTRStaphylococcal nuclease domain-containing protein 1 mRNA 3′UTR

Binding of complementary RNA sequences (such as microRNA mimics or antisense oligonucleotides) to the 3′UTR to induce mRNA degradation or translational repression of the SND1 transcript.